#USA #Washington, D.C. #Bergeson & Campbell #The Acta Group #Breanne Kincaid

Dr. Breanne J. Kincaid Joins Bergeson & Campbell, P.C.

Bergeson & Campbell, P.C. (BC) and The Acta Group (Acta) are excited to announce the addition of Dr. Breanne J. Kincaid, Ph.D., to their team as an Assistant Toxicologist and Regulatory Scientist. Dr. Kincaid brings a wealth of experience and expertise in toxicology, regulatory affairs, and environmental health, making her an invaluable asset to the firms.

Dr. Kincaid's educational background is impressive, holding a Ph.D. in Environmental Health and Engineering from the renowned Johns Hopkins Bloomberg School of Public Health. Her previous research at Johns Hopkins involved innovative methodologies in toxicology and exposure assessment, specifically focusing on developing new approach methods (NAM). This includes work on human organoid models, quantitative structure-activity relationship (QSAR) approaches, and cheminformatics, showcasing her ability to integrate cutting-edge science into practical regulatory applications.

In her new role, Dr. Kincaid will utilize her skills to assist clients with various regulatory processes, including the preparation and analysis of environmental and toxicity data essential for product approvals and compliance under regulatory frameworks such as the Toxic Substances Control Act (TSCA) and the European Union's Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). She aims to leverage her knowledge to ensure that clients not only meet regulatory requirements but do so utilizing the best available scientific evidence.

Dr. Kincaid’s experience in policy and scientific communications further enhances her fit for the role at BC and Acta. Previously, she held positions in a D.C.-based advocacy organization where she developed skills in conveying complex scientific information to diverse stakeholders. This capability will be especially beneficial in navigating the regulatory landscape, which often requires clear communication across various sectors.

Furthermore, Dr. Kincaid joins an accomplished team of professionals at Bergeson & Campbell and The Acta Group, which comprises regulatory toxicologists, chemists, biologists, and public health experts. Together, they are dedicated to providing clients with a comprehensive scientific advantage in the market, enabling them to achieve successful product launches and maintain compliance with an ever-evolving regulatory environment.

Bergeson & Campbell has established itself as a leading firm specializing in the approval and regulation of industrial, agricultural, and specialty chemical products. Their commitment to addressing both conventional and innovative products positions them as a favored choice for organizations navigating complex regulatory frameworks. In tandem, The Acta Group offers strategic consulting and compliance support, helping clients worldwide adhere to chemical regulations, ensuring both market access and sustained compliance.

Dr. Kincaid's addition is a significant step in enhancing the scientific and regulatory expertise that both BC and Acta provide to their clients. As these firms continue to expand their capabilities, they are well-positioned to support clients in making informed business decisions that align with regulatory standards while advancing public health objectives.

With her arrival, Dr. Kincaid is set to play a crucial role in the ongoing mission of Bergeson & Campbell and The Acta Group—to advocate for the application of science in regulatory evaluations and support the safe and compliant use of chemical products in various industries.